Print Save or Share

Iluvien Approval Status beta

  • FDA approved: No
  • Brand name: Iluvien
  • Generic name: fluocinolone acetonide
  • Company: pSivida Corp.
  • Treatment for: Macular Edema

Iluvien (fluocinolone acetonide) is an intravitreal implant in development for the treatment of diabetic macular edema.

FDA Approval Status for Iluvien

DateArticle
Apr  2, 2013pSivida Reports on Resubmission to FDA of NDA for Iluvien for Chronic Diabetic Macular Edema
Mar 22, 2013pSivida Reports Updates on Iluvien for Planned Resubmission to FDA and European Launch
Aug  1, 2012pSivida Corp. Reports Alimera's Intention to Resubmit Application to FDA for Iluvien in DME Using Data from Completed Trials
Nov 11, 2011pSivida Reports Receipt by Alimera Sciences of Complete Response Letter from FDA for Iluvien for DME
May 13, 2011pSivida Announces Resubmission of New Drug Application for Iluvien
Dec 26, 2010FDA Issues Complete Response Letter Regarding New Drug Application for Iluvien
Aug 31, 2010pSivida Announces Iluvien Receives FDA Priority Review for Treatment of Diabetic Macular Edema
Jun 29, 2010pSivida Announces Submission of NDA to FDA for an Ophthalmic Product for Diabetic Macular Edema

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Advertisement
Close

Recommended

(web2)